Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › dextromethorphan

dextromethorphan

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of dextromethorphan

14 trials tracked of dextromethorphan: 3 in phase 3 or 4 and 2 with published results. The most-cited published study has 16 citations.

14Trials tracked
3Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 2 Phase 3 1 Phase 2 7 Phase 1 4
  1. Phase 3 An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis Completed · 16 cited
  2. Phase 4 Effects of Isotretinoin on CYP2D6 Activity Completed · 1 cited
  3. Phase 4 Study to Evaluate Effect of Belatacept on Pharmacokinetics of Inje Cocktail in Healthy Volunteers Completed
  4. Phase 2 A Pilot Study: a Non-opioid Technique for Postoperative Adenoidectomy Pain Relief in Pediatric Patients Completed
  5. Phase 2 Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents Completed
  6. Phase 2 Dextromethorphan in Fibromyalgia Completed
Show 8 more trials
  1. Phase 2 Histamine Glutamate Antagonism in Stroke Completed
  2. Phase 2 Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan Dose Response Clinical Trial Completed
  3. Phase 2 Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination Clinical Trial Completed
  4. Phase 2 Placebo Controlled Trial of Dextromethorphan in Rett Syndrome Completed
  5. Phase 1 Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors Completed
  6. Phase 1 Study of Cobimetinib in Participants With Solid Tumors Completed
  7. Phase 1 Study of SHP620 (Maribavir) in Healthy Adults Completed
  8. Phase 1 A Study of Imlunestrant (LY3484356) in Female Healthy Participants Completed

Showing the 14 most-cited and recently-updated of 14 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
FDA Approves Auvelity (dextromethorphan/bupropion) for Major Depressive Disorder and Agitation in Alzheimer's
Psychiatry FDA Approval
FDA Approves Auvelity (dextromethorphan/bupropion) for Major Depressive Disorder and Agitation in Alzheimer's FDA approves new drug Auvelity for depression and Alzheimer's agitation.
The FDA approved Auvelity (dextromethorphan/bupropion) for major depressive disorder (MDD) and agitation associated with dementia due to Alz…
The FDA approved Auvelity for major depressive disorder and agitation in Alzheimer's disease. It combines two medicines into one pill. This …
FDA May 5, 2026